2025近期合作 & 交易事件夏天Enjoy your summer time@SUMMER01恒瑞医药与GSK达成授权合作02 BI与Re-Vana合作开发长效眼科药物03 复星医药获AD创新药物AR1001独家许可权04 泰格医药宣布收购日本CRO公司Micron05 礼来达成髓系细胞衔接器药物开发合作06石药集团与MADRIGAL达成SYH2086全球授权07 元启生物与Dr. Falk ...
Source Link2025近期合作 & 交易事件夏天Enjoy your summer time@SUMMER01恒瑞医药与GSK达成授权合作02 BI与Re-Vana合作开发长效眼科药物03 复星医药获AD创新药物AR1001独家许可权04 泰格医药宣布收购日本CRO公司Micron05 礼来达成髓系细胞衔接器药物开发合作06石药集团与MADRIGAL达成SYH2086全球授权07 元启生物与Dr. Falk ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.